细胞色素P450 2C19基因型与出血之间关联的系统评价和荟萃分析 - Suppr

Suppr

超能文献

Systematic review and meta-analysis of the association between cytochrome P450 2C19 genotype and bleeding.

作者信息

Sorich Michael J, Polasek Thomas M, Wiese Michael D

出版信息

Thromb Haemost. 2012 Jul;108(1):199-200. doi: 10.1160/TH12-02-0095. Epub 2012 May 3.

DOI:10.1160/TH12-02-0095

PMID:22552318

Abstract

摘要

相似文献

Systematic review and meta-analysis of the association between cytochrome P450 2C19 genotype and bleeding.细胞色素P450 2C19基因型与出血之间关联的系统评价和荟萃分析

Thromb Haemost. 2012 Jul;108(1):199-200. doi: 10.1160/TH12-02-0095. Epub 2012 May 3.

CYP2C19 genotype, clopidogrel metabolism, platelet function, and cardiovascular events: a systematic review and meta-analysis.CYP2C19 基因型、氯吡格雷代谢、血小板功能与心血管事件：系统评价和荟萃分析。

JAMA. 2011 Dec 28;306(24):2704-14. doi: 10.1001/jama.2011.1880.

Impact of CYP2C19 variant genotypes on clinical efficacy of antiplatelet treatment with clopidogrel: systematic review and meta-analysis.CYP2C19 基因变异对氯吡格雷抗血小板治疗临床疗效的影响：系统评价和荟萃分析。

BMJ. 2011 Aug 4;343:d4588. doi: 10.1136/bmj.d4588.

The relationship between CYP2C19 polymorphisms and ischaemic and bleeding outcomes in stable outpatients: the CHARISMA genetics study.CYP2C19 多态性与稳定门诊患者缺血和出血结局的关系：CHARISMA 遗传学研究。

Eur Heart J. 2012 Sep;33(17):2143-50. doi: 10.1093/eurheartj/ehs059. Epub 2012 Mar 26.

Clinical Pharmacogenetics Implementation Consortium guidelines for cytochrome P450-2C19 (CYP2C19) genotype and clopidogrel therapy.临床药物基因组学实施联盟 CYP2C19（细胞色素 P450-2C19）基因型和氯吡格雷治疗指南。

Clin Pharmacol Ther. 2011 Aug;90(2):328-32. doi: 10.1038/clpt.2011.132. Epub 2011 Jun 29.

Cytochrome P450 2C19 polymorphism and antiplatelet therapy. Who should really be genotyped?细胞色素 P450 2C19 多态性与抗血小板治疗。究竟应该对谁进行基因分型？

Curr Pharm Des. 2013;19(13):2489-95. doi: 10.2174/1381612811319130017.

The gain-of-function variant allele CYP2C19*17: a double-edged sword between thrombosis and bleeding in clopidogrel-treated patients.CYP2C19*17 功能获得性变异等位基因：氯吡格雷治疗患者血栓形成和出血之间的双刃剑。

J Thromb Haemost. 2012 Feb;10(2):199-206. doi: 10.1111/j.1538-7836.2011.04570.x.

Cytochrome P450 2C19 polymorphism and clopidogrel after MI.心肌梗死后细胞色素P450 2C19基因多态性与氯吡格雷

Lancet. 2009 Apr 4;373(9670):1171-2; author reply 1172-3. doi: 10.1016/S0140-6736(09)60680-2.

Cytochrome 2C19*17 allelic variant, platelet aggregation, bleeding events, and stent thrombosis in clopidogrel-treated patients with coronary stent placement.细胞色素 2C19*17 等位基因变异、血小板聚集、出血事件和氯吡格雷治疗的冠状动脉支架置入患者的支架血栓形成。

Circulation. 2010 Feb 2;121(4):512-8. doi: 10.1161/CIRCULATIONAHA.109.885194. Epub 2010 Jan 18.

Cytochrome P450 2C19 polymorphism is associated with poor clinical outcomes in coronary artery disease patients treated with clopidogrel.细胞色素 P450 2C19 多态性与接受氯吡格雷治疗的冠心病患者的临床预后不良相关。

Mol Biol Rep. 2011 Mar;38(3):1697-702. doi: 10.1007/s11033-010-0282-0. Epub 2010 Sep 16.

引用本文的文献

Effect of CYP2C19 Genotype on Ischemic Outcomes During Oral P2Y Inhibitor Therapy: A Meta-Analysis.CYP2C19 基因型对口服 P2Y 抑制剂治疗期间缺血结局的影响：一项荟萃分析。

JACC Cardiovasc Interv. 2021 Apr 12;14(7):739-750. doi: 10.1016/j.jcin.2021.01.024. Epub 2021 Mar 17.

Next-Generation Sequencing of CYP2C19 in Stent Thrombosis: Implications for Clopidogrel Pharmacogenomics.支架血栓形成中 CYP2C19 的下一代测序：氯吡格雷药物基因组学的意义。

Cardiovasc Drugs Ther. 2021 Jun;35(3):549-559. doi: 10.1007/s10557-020-06988-w.

Analysis of the CYP2C19 genotype associated with bleeding in Serbian STEMI patients who have undergone primary PCI and treatment with clopidogrel.对接受直接经皮冠状动脉介入治疗（primary PCI）并使用氯吡格雷治疗的塞尔维亚ST段抬高型心肌梗死（STEMI）患者中与出血相关的CYP2C19基因型的分析。

Eur J Clin Pharmacol. 2018 Apr;74(4):443-451. doi: 10.1007/s00228-017-2401-5. Epub 2017 Dec 19.

The pharmacogenetic control of antiplatelet response: candidate genes and CYP2C19.抗血小板反应的药物遗传学控制：候选基因与CYP2C19

Expert Opin Drug Metab Toxicol. 2015;11(10):1599-617. doi: 10.1517/17425255.2015.1068757. Epub 2015 Jul 14.

CYP2C19 polymorphism and clinical outcomes among patients of different races treated with clopidogrel: A systematic review and meta-analysis.不同种族接受氯吡格雷治疗患者的CYP2C19基因多态性与临床结局：一项系统评价和荟萃分析。

J Huazhong Univ Sci Technolog Med Sci. 2015 Apr;35(2):147-156. doi: 10.1007/s11596-015-1404-7. Epub 2015 Apr 16.

Pharmacogenomic substudies of randomized controlled trials: consideration of safety outcomes.随机对照试验的药物基因组学子研究：对安全性结果的考量

Ther Adv Drug Saf. 2014 Apr;5(2):62-6. doi: 10.1177/2042098613520030.

Clinical Pharmacogenetics Implementation Consortium guidelines for CYP2C19 genotype and clopidogrel therapy: 2013 update.临床药物遗传学实施联盟 CYP2C19 基因型和氯吡格雷治疗指南：2013 年更新。

Clin Pharmacol Ther. 2013 Sep;94(3):317-23. doi: 10.1038/clpt.2013.105. Epub 2013 May 22.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验